Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil
- PMID: 34562526
- PMCID: PMC8457917
- DOI: 10.1016/j.ajic.2021.09.018
Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil
Abstract
Background: The impact of COVID-19 on healthcare- associated infections (HCAI) caused by multidrug-resistant (MDR) bacteria that contribute to higher mortality is a growing area of study METHODS: This retrospective observational study compares the incidence density (ID) of HCAI caused by MDR bacteria (CRE, CRAB, CRP, MRSA and VRE) pre-COVID (2017-2019) and during the COVID-19 pandemic (2020) in overall hospitalized patients and in intensive care (ICU) units.
Results: We identified 8,869 HCAI, of which 2,641 (29.7%) were caused by bacterial MDR, and 1,257 (14.1%) were from ICUs. The overall ID of MDR infections increased 23% (P < .005) during COVID-19. The overall per-pathogen analysis shows significant increases in infections by CRAB and MRSA (+108.1%, p<0.005; +94.7%, p<0.005, respectively), but not in CRE, CRP, or VRE. In the ICU, the overall ID of MDR infections decreased during COVID, but that decline was not significant (-6.5%, P = .26). The ICU per-pathogen analysis of ID of infection showed significant increases in CRAB and MRSA (+42.0%, P = .001; +46.2%, P = .04), significant decreases in CRE and CRP (-26.4%, P = .002; -44.2%, P = 0.003, respectively) and no change in VRE.
Conclusions: The COVID-19 pandemic correlates to an increase in ID of CRAB and MRSA both in ICU and non-ICU setting, and a decrease in ID of CRE and CRP in the ICU setting. Infection control teams should be aware of possible outbreaks of CRAB and MRSA and promote rigorous adherence to infection control measures as practices change to accommodate changes in healthcare needs during and after the pandemic.
Keywords: Carbapenem-resistant Acinetobacter baumannii infection; Epidemiology; Healthcare-associated infections; Methicillin-resistant Staphylococcus aureus infection; Multidrug resistant bacteria; Multidrug resistant infection.
Copyright © 2021 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
Figures




Comment in
-
Transitional impact on Acinetobacter baumannii MDR infections in 5 Brazilian ICUs in 2020.Am J Infect Control. 2022 Feb;50(2):239-240. doi: 10.1016/j.ajic.2021.10.013. Am J Infect Control. 2022. PMID: 35101182 No abstract available.
References
-
- World Health Organization. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19): interim guidance, 19 March 2020. No. WHO/2019-nCoV/IPC PPE_use/2020.2. World Health Organization, 2020.
-
- Cookson C. Scientists alarmed at spread of Covid mutant. December 20, 2020. Available at: https://advance.lexis.com/api/document?collection=news&id=urn:contentIte.... Accessed February 18, 2021
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous